Qtern Comprimés pelliculés Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

qtern comprimés pelliculés

astrazeneca ag - dapagliflozinum, saxagliptinum - comprimés pelliculés - dapagliflozinum 10 mg ut dapagliflozinum propandiolum monohydricum, saxagliptinum 5 mg ut saxagliptini hydrochloridum, cellulosum microcristallinum, lactosum 40 mg, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, acidum hydrochloridum, natrii hydroxidum, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: e 132, lacca, pro compresso obducto corresp. natrium max. 0.91 mg. - antidiabetikum - synthetika

Fasenra Solution injectable Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

fasenra solution injectable

astrazeneca ag - benralizumabum - solution injectable - benralizumabum 30 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile ad solutionem pro 1 ml. - schweres eosinophiles de l'asthme - biotechnologika

Lynparza 100 mg Comprimés pelliculés Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

lynparza 100 mg comprimés pelliculés

astrazeneca ag - olaparibum - comprimés pelliculés - olaparibum 100 mg, copovidonum k 28, silica colloidalis anhydrica, mannitolum, natrii stearylis fumaras corresp. natrium 0.236 mg, Überzug: hypromellosum, macrogolum 400, e 171, e 172 (flavum), pro compresso obducto. - onkologikum - synthetika

Lynparza 150 mg Comprimés pelliculés Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

lynparza 150 mg comprimés pelliculés

astrazeneca ag - olaparibum - comprimés pelliculés - olaparibum 150 mg, copovidonum k 28, silica colloidalis anhydrica, mannitolum, natrii stearylis fumaras corresp. natrium 0.354 mg, Überzug: hypromellosum, macrogolum 400, e 171, e 172 (flavum), e 172 (nigrum), pro compresso obducto. - onkologikum - synthetika

Brilique 90 mg Les comprimés orodispersibles Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

brilique 90 mg les comprimés orodispersibles

astrazeneca ag - ticagrelorum - les comprimés orodispersibles - ticagrelorum 90 mg, mannitolum, cellulosum microcristallinum, crospovidonum, xylitolum, calcii hydrogenophosphas, natrii stearylis fumaras, hydroxypropylcellulosum, silica colloidalis anhydrica, pro compresso corresp. natrium 0.53 mg. - thrombozytenaggregationshemmung en association avec l'acide acétylsalicylique - synthetika

Fasenra Pen 30 mg /1 ml lnjektionslösung Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

fasenra pen 30 mg /1 ml lnjektionslösung

astrazeneca ag - benralizumabum - lnjektionslösung - benralizumabum 30 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - schweres eosinophiles de l'asthme - biotechnologika

Bydureon BCise 2 mg Depot-lnjektionssuspension in einem Autoinjektor Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

bydureon bcise 2 mg depot-lnjektionssuspension in einem autoinjektor

astrazeneca ag - exenatidum - depot-lnjektionssuspension in einem autoinjektor - exenatidum 2 mg, saccharum, poly(lactidum-co-glycolidum) 50/50 (0.40 - 0.49 dl/g), triglycerida media, ad suspensionem pro dosi. - antidiabetikum - synthetika

Calquence 100 mg Gélules Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

calquence 100 mg gélules

astrazeneca ag - acalabrutinibum - gélules - acalabrutinibum 100 mg, cellulosum microcristallinum silicificatum, amylum pregelificatum, carboxymethylamylum natricum a corresp. natrium max. 0.25 mg, magnesii stearas, kapselhülle: gelatina, e 172 (flavum), e 132, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula. - chronisch lymphatische leukämie (cll) - synthetika

Trixeo Aerosphere 5/7.2/160 μg Druckgasinhalation, Suspension Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

trixeo aerosphere 5/7.2/160 μg druckgasinhalation, suspension

astrazeneca ag - budesonidum, glycopyrronium, formoteroli fumaras dihydricus - druckgasinhalation, suspension - budesonidum 160 µg, glycopyrronii bromidum 9 µg corresp. glycopyrronium 7.2 µg, formoteroli fumaras dihydricus 5 µg, 1,2-distearoyl-sn-glycero-3-phosphocholinum, calcii chloridum dihydricum, norfluranum, ad suspensionem pro dosi. - la mpoc - synthetika

Tezspire Solution injectable dans une seringue Préremplie Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

tezspire solution injectable dans une seringue préremplie

astrazeneca ag - tezepelumabum - solution injectable dans une seringue préremplie - tezepelumabum 210 mg, prolinum, acidum aceticum glaciale, polysorbatum 80, natrii hydroxidum q.s. ad ph, aqua ad iniectabile, ad solutionem pro 1.91 ml. - zusatztherapie bei schwerem asthma - biotechnologika